Skip to main content

Table 3 Multivariate analysis for overall survival and progression free survival in patients with PTCL- NOS

From: Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy

 

OS

P-value

HR (95% CI)

PFS

P-value

HR (95% CI)

IPI

    

   L, LI

< 0.001

4.06 (95% CI 2.40-6.84)

< 0.001

2.43 (95% CI 1.51-3.90)

   HI, H

    

ALC

    

   ≥ 1.0 × 109/l

0.002

2.24 (95% CI 1.33-3.78)

0.008

1.94 (95% CI 1.19-3.18)

   < 1.0 × 109/l

    
  1. IPI, International Prognostic Index; L, low; LI, low-intermediate; HI, high-intermediate; H, high; ALC, absolute lymphocyte count; OS, overall survival; PFS, progression free survival.
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us